Radioembolization (Y-90 Therapy) in India
_____________________________
Schedule Consultation
– Start Online Consultation
If you or your loved one is considering Radioembolization (Y-90 Therapy), early evaluation is crucial for better outcomes. Fuda Cancer Centre provides dedicated support to patients across India. There is no need to travel initially — you can begin with an online consultation from the comfort of your home.
Our expert Dr. Anup Aboti will carefully review your PET/CT scans, MRI reports, liver function tests, and medical history to determine whether Y-90 Radioembolization is the right treatment option for your condition. Fill out the form today to schedule your consultation.
Start Online Consultation →Radioembolization (Y-90 Therapy) is an advanced, minimally invasive treatment used primarily for liver cancers. Patients from India can receive expert evaluation through online consultation before planning treatment. This therapy delivers targeted radiation directly to liver tumours while preserving surrounding healthy tissue.
What Is Radioembolization (Y-90 Therapy)?
Y-90 Radioembolization, also known as Selective Internal Radiation Therapy (SIRT), is a specialised procedure that uses tiny radioactive microspheres containing Yttrium-90. These microspheres are delivered directly into the blood vessels feeding liver tumours.
Once inside, they emit radiation that destroys cancer cells from within, reducing tumour size and slowing disease progression.
Why Y-90 Therapy Is Gaining Popularity in India
- Minimally invasive and targeted treatment
- Specifically effective for liver tumours
- Preserves healthy liver tissue
- Can be used when surgery is not possible
- Short hospital stay and faster recovery
- Suitable for advanced or inoperable cancers
Many patients consider Y-90 therapy when conventional treatments like surgery or chemotherapy are not suitable or effective.
Who May Benefit From Y-90 Therapy
Eligibility depends on liver function, tumour size, and overall health. Doctors evaluate imaging scans and clinical reports before recommending treatment. It may be considered for:
- Primary liver cancer (Hepatocellular carcinoma - HCC)
- Liver metastases from other cancers
- Unresectable or inoperable tumours
- Patients not responding to chemotherapy
- Patients seeking targeted liver-directed therapy
Advanced imaging such as CT, MRI, and PET scans are used to determine suitability.
Types of Cancer Treated With Y-90
- Hepatocellular carcinoma (HCC)
- Metastatic colorectal cancer (liver metastases)
- Neuroendocrine tumour liver metastases
- Cholangiocarcinoma (bile duct cancer)
- Breast cancer liver metastases
Procedure Timeline & Recovery
Before Treatment
- Mapping angiography to assess liver blood supply
- Planning and safety evaluation
Day of Treatment
- Catheter-based delivery of Y-90 microspheres
- Performed under imaging guidance
- Short hospital stay or same-day discharge
After Treatment
- Mild fatigue, nausea, or abdominal discomfort
- Return to routine activities within a few days
- Follow-up imaging to assess tumour response
Recovery varies depending on liver condition and tumour burden.
Alternative or Supportive Treatments
- Transarterial chemoembolization (TACE)
- Systemic chemotherapy
- Targeted therapy or immunotherapy
- Liver surgery (selected patients)
- Palliative and supportive care
Y-90 therapy is often part of a multidisciplinary liver cancer treatment plan.
Treatment Comparison
| Treatment | Approach | Recovery | Targeting |
|---|---|---|---|
| Y-90 Therapy | Internal targeted radiation | Short | Highly targeted |
| Chemotherapy | Systemic drug therapy | Variable | Broad |
| Surgery | Invasive removal | Longer | Localised |
| TACE | Chemoembolization | Moderate | Targeted |
How to Choose the Right Y-90 Centre
- Expertise in interventional radiology
- Advanced imaging facilities (CT/MRI/PET)
- Multidisciplinary cancer team
- Experience with liver-directed therapies
- Structured follow-up care
How Indian Patients Can Get Started
Patients can share their CT/MRI scans, biopsy reports, and medical history online for expert evaluation. Doctors provide eligibility assessment, treatment planning, and guidance before any hospital visit.
Benefits for Indian Patients
- Online consultation from home
- Minimally invasive treatment option
- Short hospital stay
- Faster recovery time
- Personalised treatment planning
- Continuous monitoring and support
Y-90 Radioembolization represents a major advancement in liver cancer treatment. Specialists create personalised plans to improve outcomes while maintaining quality of life.
Alternatives & When They Fit Better
Radioembolization (Y-90 Therapy) is a highly specialised liver-directed treatment. However, it is not always the first option. Doctors assess tumour size, liver function, cancer spread, and prior treatments before recommending the most suitable approach.
- TACE (Transarterial Chemoembolization) – Commonly used for intermediate-stage liver cancer
- Systemic Therapy – Includes targeted therapy or immunotherapy for advanced disease
- Chemotherapy – Used when cancer has spread beyond the liver
- Surgery – Best for early-stage, resectable liver tumours
- Ablation Therapy – Suitable for small, localised tumours
Y-90 therapy is often recommended when tumours are unresectable or when a targeted liver-specific treatment is required.
Latest Updates & What’s Changing
Y-90 Radioembolization continues to evolve with advances in interventional radiology and imaging technology. These improvements aim to enhance precision, safety, and treatment outcomes.
- Advanced angiographic mapping for precise microsphere delivery
- Improved dosimetry planning for personalised treatment
- Better imaging techniques (CT/MRI/PET) for patient selection
- Enhanced radiation safety protocols
- Refined patient monitoring and follow-up strategies
Ongoing research is focused on combining Y-90 therapy with systemic treatments for improved survival outcomes.
Key Differences: Side-by-Side
| Treatment | Main Purpose | Targeting Precision | Body Impact |
|---|---|---|---|
| Y-90 Therapy | Deliver radiation directly to liver tumours | Highly targeted | Localized effect within liver |
| Chemotherapy | Destroy rapidly dividing cancer cells | Broad | Systemic side effects |
| Targeted / Immunotherapy | Block cancer growth pathways | Moderate to high | Drug-specific effects |
| Surgery | Remove tumour tissue | Localised | Invasive procedure |
| TACE | Block blood supply + deliver chemo | Targeted | Moderate liver impact |
Each treatment plays a different role in liver cancer management. In many cases, therapies are combined for optimal outcomes.
Cost & Ongoing Needs
Y-90 therapy requires specialised infrastructure, trained interventional radiologists, and strict radiation handling protocols. Costs may vary depending on treatment complexity and patient condition.
- One or two treatment sessions depending on liver involvement
- Use of Yttrium-90 microspheres
- Pre-treatment mapping procedure required
- Imaging and lab investigations included
- Follow-up scans to evaluate response
- Regular monitoring of liver function
Patients should discuss complete treatment planning, expected outcomes, and financial aspects with their medical team.
Preparing for Y-90 Therapy
Preparation is essential to ensure safety and maximise treatment effectiveness. Doctors provide personalised instructions based on patient condition.
- Detailed CT/MRI and angiographic mapping
- Evaluation of liver and kidney function
- Assessment of tumour distribution
- Temporary medication adjustments if needed
- Fasting and hydration instructions
- Radiation safety counselling
Proper preparation helps reduce risks and improves treatment accuracy.
Long-Term Outcomes and Survival Expectations
Outcomes vary based on cancer type, liver function, tumour burden, and overall health. Y-90 therapy aims to control disease progression and improve quality of life.
- Tumour shrinkage or stabilisation in many patients
- Symptom relief and improved liver function
- Can extend survival in selected cases
- May convert inoperable tumours to operable
- Requires regular follow-up imaging
Doctors provide personalised outcome expectations based on clinical findings and imaging results.
Why Choose Fuda Cancer Hospital for Radioembolization (Y-90 Therapy) in India?
Expert-led liver cancer care with advanced interventional radiology, precise treatment planning, and structured support for patients across India.
Specialised Experience in Y-90 Radioembolization with Indian Patient Support
Precision Treatment Planning Using Advanced Imaging & Dosimetry
Multidisciplinary Liver Cancer Management Approach
Careful Evaluation for Advanced, Inoperable, or Recurrent Liver Tumours
Structured Monitoring, Safety Protocols & Long-Term Follow-Up
Radioembolization (Y-90 Therapy) Treatment
Advanced liver-directed therapy using Yttrium-90 microspheres, designed for precise targeting of liver tumours, helping control disease progression, reduce tumour burden, and maintain quality of life for patients across India.
What Is Radioembolization (Y-90 Therapy)?
- Y-90 Radioembolization (Selective Internal Radiation Therapy – SIRT): A specialised interventional radiology procedure used to treat liver tumours by delivering radioactive microspheres directly into tumour-feeding blood vessels.
- The microspheres contain Yttrium-90, a radioactive isotope that emits radiation locally within the tumour.
- This approach allows high-dose radiation delivery to cancer cells while minimising exposure to surrounding healthy liver tissue.
- The treatment is performed using a catheter inserted through blood vessels, guided by imaging for precise placement.
- Y-90 therapy is usually performed in one or two sessions and requires careful planning and follow-up monitoring.
Conditions Commonly Treated with Y-90 Therapy
- Hepatocellular carcinoma (HCC)
- Liver metastases from colorectal cancer
- Neuroendocrine tumour liver metastases
- Cholangiocarcinoma (bile duct cancer)
- Breast cancer liver metastases
- Unresectable or inoperable liver tumours
- Recurrent liver cancers
- Patients not responding to chemotherapy or systemic therapy
Why Y-90 Therapy Is Important for Patients in India
Y-90 Radioembolization provides an important treatment option for patients with liver-dominant cancers, especially when surgery is not feasible or when disease progresses despite standard treatments.
The therapy delivers radiation directly inside the tumour, helping achieve tumour control and disease stabilisation while limiting systemic side effects.
It is often considered for advanced or metastatic cases, offering a targeted approach when other options are limited.
With proper patient selection, imaging guidance, and structured follow-up, Y-90 therapy supports long-term disease management and helps preserve liver function and overall quality of life.
Frequently Asked Questions – Radioembolization (Y-90 Therapy)
Common questions patients ask about Y-90 therapy, eligibility, procedure, safety, and treatment planning
What is Radioembolization (Y-90 Therapy)?
Radioembolization (Y-90 Therapy), also known as Selective Internal Radiation Therapy (SIRT), is a minimally invasive treatment used primarily for liver cancers. It delivers tiny radioactive microspheres (Yttrium-90) directly into the blood vessels supplying the tumour, allowing targeted radiation within the liver.
Which patients are eligible for Y-90 therapy?
Y-90 therapy is typically considered for patients with primary liver cancer (HCC) or liver-dominant metastases. Doctors evaluate liver function, tumour size and location, blood supply, prior treatments, and overall health before recommending this therapy.
Is Y-90 therapy a form of chemotherapy?
No. Y-90 therapy is not chemotherapy. It is a targeted radiation treatment delivered directly to liver tumours through the blood vessels, minimising systemic exposure compared to chemotherapy.
How is Y-90 therapy performed?
The procedure is performed by an interventional radiologist using a catheter inserted through the blood vessels. After detailed mapping, radioactive microspheres are delivered precisely to tumour-feeding arteries under imaging guidance.
What are the possible side effects of Y-90 therapy?
Most patients tolerate Y-90 therapy well. Some may experience fatigue, mild abdominal discomfort, or nausea. Liver function is monitored closely after treatment to ensure safety.
How many sessions of Y-90 therapy are required?
Y-90 therapy is usually performed in one or two treatment sessions, depending on whether one or both lobes of the liver are involved. Doctors determine the treatment plan based on imaging and clinical evaluation.
Can Y-90 therapy be combined with other treatments?
Yes. Y-90 therapy may be combined with systemic treatments such as targeted therapy, immunotherapy, or chemotherapy, depending on tumour type and disease progression.
Is Y-90 therapy suitable for advanced or inoperable tumours?
Y-90 therapy is commonly used for patients with inoperable or advanced liver tumours, especially when surgery is not possible or when other treatments are not effective.
How can patients start the evaluation process?
Patients can begin with an online consultation by sharing CT/MRI scans, biopsy reports, and previous treatment records. Specialists review the case and provide personalised guidance before planning treatment.
Our Specialties & Procedures
Explore our range of advanced cancer care procedures designed to provide comprehensive treatment and improve your well-being.
Advanced Therapies For Cancer
Innovative and precise cancer treatments combining advanced technology, targeted therapy, and personalized medicine for better recovery outcomes.
Explore More →
Treating Specific Cancer
Specialized treatment plans for different cancer types — including liver, lung, breast, and bone cancers — with a focus on patient comfort and long-term wellness.
Explore More →Our Specialties & Procedures
Explore our range of advanced cancer care procedures designed to provide comprehensive treatment and improve your well-being.
Advanced Therapies For Cancer
Innovative and precise cancer treatments combining advanced technology, targeted therapy, and personalized medicine for better recovery outcomes.
Explore More →
Treating Specific Cancer
Specialized treatment plans for different cancer types — including liver, lung, breast, and bone cancers — with a focus on patient comfort and long-term wellness.
Explore More →ABOUT FUDA CANCER HOSPITAL
OUR ACHIEVEMENTS
Achievements of FUDA CANCER HOSPITAL
50+ Doctors
Professional Experts
1200+ Patients
Happy Indian Patients
100+ Countries
Global Presence
500+ Employees
Dedicated Workforce
Advanced Therapies for Cancer of All Stages
Nano Knife IRE (Irreversible Electroporation)
Cryotherapy | Cryosurgery | Cryo-ablation
Brachytherapy for Cancer
Microvascular Interventional Chemotherapy
Patient Testimonials
Mrs. Pratibha Rajgopal
Mrs. Dipikabehan Parmar
Mrs. Roseline Chandran
Mrs. Jyoti Bhatia